LivaNova Announces Availability of Safety and Technical Information for Valve-in-Valve Procedures on Perceval Platform

February 25, 2019 by Website Admin in

LivaNova PLC, a market-leading medical technology company, announced today that given the increasing viability of Valve-in-Valve (ViV) procedures, it has added new safety and technical information to the Perceval U.S. Instructions For Use (IFUs).

Tweet

Share

Pin it

Previous StoryLivaNova’s Perceval Sutureless Aortic Heart Valve Receives National Reimbursement in Japan to Treat Patients with Aortic Valve Disease Next StoryMarker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019